Other Issues:		[Index by Author]
Contents:	Volume 27, Issue 18 June 20, 2009

	JCO YIA
	EDITORIALS
	COMMENTS AND CONTROVERSIES
	ORIGINAL REPORTS
	Palliative and Supportive Care
	Melanoma
	Genitourinary Cancer
	Breast Cancer
	Head and Neck Cancer
	Leukemia and Bone Marrow Transplantation
	Thoracic Oncology
	Gastrointestinal Cancer
	Lymphoma and Myeloma
	ASCO SPECIAL ARTICLE
	DIAGNOSIS IN ONCOLOGY
	CORRESPONDENCE
	ERRATA

Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

                                      JCO YIA

Journal Honors Phoenix A. Ho, MD, As Recipient of the 2009 JCO Young Investigator Award JCO Jun 2009: 2893. First published on May 26 2009; 10.1200/JCO.2009.23.7495. [Full Text] [PDF]

                                      EDITORIALS

Care of the Caregiver: Stress and Dysregulation of Inflammatory Control in Cancer Caregivers Susan K. Lutgendorf and Mark L. Laudenslager JCO Jun 2009: 2894–2895. First published on May 11 2009; 10.1200/JCO.2009.22.1523. [Full Text] [PDF]

Interferon Alfa in the Postsurgical Management of High-Risk Melanoma: Is It Worth It? John Glaspy, Antoni Ribas, and Bartosz Chmielowski JCO Jun 2009: 2896–2897. First published on May 11 2009; 10.1200/JCO.2009.22.2133. [Full Text] [PDF]

Is There a Standard of Care for Pathologic Stage T3 Prostate Cancer? Ian M. Thompson, Catherine M. Tangen, and Eric A. Klein JCO Jun 2009: 2898–2899. First published on May 11 2009; 10.1200/JCO.2008.20.9460. [Full Text] [PDF]

Age and Lymph Node Status in Breast Cancer: Not a Straightforward Relationship Eleftherios P. Mamounas JCO Jun 2009: 2900–2901. First published on May 18 2009; 10.1200/JCO.2009.22.0509. [Full Text] [PDF]

Prognostic Tools for Cancer Survival: A Secondary Role for Quality-of-Life Measurement George P. Browman, Tanya Berrang, and Sally Smith JCO Jun 2009: 2902–2904. First published on May 18 2009; 10.1200/JCO.2009.21.8438. [Full Text] [PDF]

                                      COMMENTS AND CONTROVERSIES

End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen, David R. Macdonald, and Susan M. Chang JCO Jun 2009: 2905–2908. First published on May 18 2009; 10.1200/JCO.2009.22.4998. [Full Text] [PDF]

                                      ORIGINAL REPORTS
Palliative and Supportive Care

Biologic Cost of Caring for a Cancer Patient: Dysregulation of Pro- and Anti-Inflammatory Signaling Pathways Nicolas Rohleder, Teresa J. Marin, Roy Ma, and Gregory E. Miller JCO Jun 2009: 2909–2915. First published on May 11 2009; 10.1200/JCO.2008.18.7435. [Abstract] [Full Text] [PDF]

Melanoma

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group Andrew Bottomley, Corneel Coens, Stefan Suciu, Mario Santinami, Willem Kruit, Alessandro Testori, Jeremy Marsden, Cornelis Punt, François Salès, Martin Gore, Rona MacKie, Zvonko Kusic, Reinhard Dummer, Poulam Patel, Dirk Schadendorf, Alain Spatz, Ulrich Keilholz, and Alexander Eggermont JCO Jun 2009: 2916–2923. First published on May 11 2009; 10.1200/JCO.2008.20.2069. [Abstract] [Full Text] [PDF] [Publisher's Note]

Genitourinary Cancer

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95 Thomas Wiegel, Dirk Bottke, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Norman Willich, Axel Semjonow, Rainer Souchon, Michael Stöckle, Christian Rübe, Lothar Weißbach, Peter Althaus, Udo Rebmann, Tilman Kälble, Horst Jürgen Feldmann, Manfred Wirth, Axel Hinke, Wolfgang Hinkelbein, and Kurt Miller JCO Jun 2009: 2924–2930. First published on May 11 2009; 10.1200/JCO.2008.18.9563. [Abstract] [Full Text] [PDF] [French PDF]

Breast Cancer

Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer Hans Wildiers, Ben Van Calster, Lonneke V. van de Poll-Franse, Wouter Hendrickx, Jo Røislien, Ann Smeets, Robert Paridaens, Karen Deraedt, Karin Leunen, Caroline Weltens, Sabine Van Huffel, Marie-Rose Christiaens, and Patrick Neven JCO Jun 2009: 2931–2937. First published on May 18 2009; 10.1200/JCO.2008.16.7619. [Abstract] [Full Text] [PDF]

Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer Michael Untch, Volker Möbus, Walther Kuhn, Bernd Rudolph Muck, Christoph Thomssen, Ingo Bauerfeind, Nadia Harbeck, Christoph Werner, Annette Lebeau, Andreas Schneeweiss, Stephen Kahlert, Franz von Koch, Karl Ulrich Petry, Diethelm Wallwiener, Rolf Kreienberg, Ute-Susann Albert, Hans-Joachim Lück, Axel Hinke, Fritz Jänicke, and Gottfried E. Konecny JCO Jun 2009: 2938–2945. First published on Apr 13 2009; 10.1200/JCO.2008.20.3133. [Abstract] [Full Text] [PDF]

Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer Karl Y. Bilimoria, David J. Bentrem, Nora M. Hansen, Kevin P. Bethke, Alfred W. Rademaker, Clifford Y. Ko, David P. Winchester, and David J. Winchester JCO Jun 2009: 2946–2953. First published on Apr 13 2009; 10.1200/JCO.2008.19.5750. [Abstract] [Full Text] [PDF]

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane Linda T. Vahdat, Brian Pruitt, Carol J. Fabian, Ragene R. Rivera, David A. Smith, Elizabeth Tan-Chiu, Jonathan Wright, Antoinette R. Tan, Noshir A. DaCosta, Ellen Chuang, John Smith, Joyce O'Shaughnessy, Dale E. Shuster, Nicole L. Meneses, Kumari Chandrawansa, Fang Fang, Patricia E. Cole, Simon Ashworth, and Joanne L. Blum JCO Jun 2009: 2954–2961. First published on Apr 6 2009; 10.1200/JCO.2008.17.7618. [Abstract] [Full Text] [PDF]

Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial Mitch Dowsett, Marion Procter, Worta McCaskill-Stevens, Evandro de Azambuja, Urania Dafni, Josef Rueschoff, Bruce Jordan, Stella Dolci, Mark Abramovitz, Oliver Stoss, Giuseppe Viale, Richard D. Gelber, Martine Piccart-Gebhart, and Brian Leyland-Jones JCO Jun 2009: 2962–2969. First published on Apr 13 2009; 10.1200/JCO.2008.19.7939. [Abstract] [Full Text] [PDF]

Head and Neck Cancer

Health-Related Quality of Life As a Survival Predictor for Patients With Localized Head and Neck Cancer Treated With Radiation Therapy François Meyer, André Fortin, Michel Gélinas, Abdenour Nabid, François Brochet, Bernard Têtu, and Isabelle Bairati JCO Jun 2009: 2970–2976. First published on May 18 2009; 10.1200/JCO.2008.20.0295. [Abstract] [Full Text] [PDF]

BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid Cancer Mingzhao Xing, Douglas Clark, Haixia Guan, Meiju Ji, Alan Dackiw, Kathryn A. Carson, Matthew Kim, Anthony Tufaro, Paul Ladenson, Martha Zeiger, and Ralph Tufano JCO Jun 2009: 2977–2982. First published on May 4 2009; 10.1200/JCO.2008.20.1426. [Abstract] [Full Text] [PDF]

Leukemia and Bone Marrow Transplantation

Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia Robert J. Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, Pierre Noel, David J.P. FitzGerald, Wyndham H. Wilson, and Ira Pastan JCO Jun 2009: 2983–2990. First published on May 4 2009; 10.1200/JCO.2008.20.2630. [Abstract] [Full Text] [PDF]

Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy Peter J. Campbell, David Bareford, Wendy N. Erber, Bridget S. Wilkins, Penny Wright, Georgina Buck, Keith Wheatley, Claire N. Harrison, and Anthony R. Green JCO Jun 2009: 2991–2999. First published on Apr 13 2009; 10.1200/JCO.2008.20.3174. [Abstract] [Full Text] [PDF]

Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data–Based Meta-Analysis of the German Acute Myeloid Leukemia Intergroup Jürgen Krauter, Katharina Wagner, Irina Schäfer, Rolf Marschalek, Claus Meyer, Gerhard Heil, Markus Schaich, Gerhard Ehninger, Dietger Niederwieser, Rainer Krahl, Thomas Büchner, Cristina Sauerland, Brigitte Schlegelberger, Konstanze Döhner, Hartmut Döhner, Richard F. Schlenk, and Arnold Ganser JCO Jun 2009: 3000–3006. First published on Apr 20 2009; 10.1200/JCO.2008.16.7981. [Abstract] [Full Text] [PDF]

Thoracic Oncology

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma Lee M. Krug, Harvey I. Pass, Valerie W. Rusch, Hedy L. Kindler, David J. Sugarbaker, Kenneth E. Rosenzweig, Raja Flores, Joseph S. Friedberg, Katherine Pisters, Matthew Monberg, Coleman K. Obasaju, and Nicholas J. Vogelzang JCO Jun 2009: 3007–3013. First published on Apr 13 2009; 10.1200/JCO.2008.20.3943. [Abstract] [Full Text] [PDF]

Phase II Study of Tirapazamine, Cisplatin, and Etoposide and Concurrent Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: SWOG 0222 Quynh-Thu X. Le, James Moon, Mary Redman, Stephen K. Williamson, Primo N. Lara, Jr, Zelanna Goldberg, Laurie E. Gaspar, John J. Crowley, Dennis F. Moore, Jr, and David R. Gandara JCO Jun 2009: 3014–3019. First published on Apr 13 2009; 10.1200/JCO.2008.21.3868. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study Christopher G. Willett, Dan G. Duda, Emmanuelle di Tomaso, Yves Boucher, Marek Ancukiewicz, Dushyant V. Sahani, Johanna Lahdenranta, Daniel C. Chung, Alan J. Fischman, Gregory Y. Lauwers, Paul Shellito, Brian G. Czito, Terence Z. Wong, Erik Paulson, Martin Poleski, Zeljko Vujaskovic, Rex Bentley, Helen X. Chen, Jeffrey W. Clark, and Rakesh K. Jain JCO Jun 2009: 3020–3026. First published on May 26 2009; 10.1200/JCO.2008.21.1771. [Abstract] [Full Text] [PDF]

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study Andrew X. Zhu, Dushyant V. Sahani, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Onofrio A. Catalano, Vivek Sindhwani, Lawrence S. Blaszkowsky, Sam S. Yoon, Johanna Lahdenranta, Pankaj Bhargava, Jeffrey Meyerhardt, Jeffrey W. Clark, Eunice L. Kwak, Aram F. Hezel, Rebecca Miksad, Thomas A. Abrams, Peter C. Enzinger, Charles S. Fuchs, David P. Ryan, and Rakesh K. Jain JCO Jun 2009: 3027–3035. First published on May 26 2009; 10.1200/JCO.2008.20.9908. [Abstract] [Full Text] [PDF]

Lymphoma and Myeloma

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma Arnold Freedman, Sattva S. Neelapu, Craig Nichols, Michael J. Robertson, Benjamin Djulbegovic, Jane N. Winter, John F. Bender, Daniel P. Gold, Richard G. Ghalie, Morgan E. Stewart, Vanessa Esquibel, and Paul Hamlin JCO Jun 2009: 3036–3043. First published on May 4 2009; 10.1200/JCO.2008.19.8903. [Abstract] [Full Text] [PDF]

Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study Theresa H.M. Keegan, Laura A. McClure, James M. Foran, and Christina A. Clarke JCO Jun 2009: 3044–3051. First published on May 18 2009; 10.1200/JCO.2008.18.8052. [Abstract] [Full Text] [PDF]

                                      ASCO SPECIAL ARTICLE

Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps—From the American Society of Clinical Oncology Frank D. Ferris, Eduardo Bruera, Nathan Cherny, Charmaine Cummings, David Currow, Deborah Dudgeon, Nora JanJan, Florian Strasser, Charles F. von Gunten, and Jamie H. Von Roenn JCO Jun 2009: 3052–3058. First published on May 18 2009; 10.1200/JCO.2008.20.1558. [Abstract] [Full Text] [PDF]

                                      DIAGNOSIS IN ONCOLOGY

Hematodermic Tumor Presenting With Generalized Skin Involvement Alvaro J. Alencar, Ernesto Bustinza, Jennifer Barker, Gerald E. Byrne, and Izidore S. Lossos JCO Jun 2009: 3059–3061. First published on May 4 2009; 10.1200/JCO.2009.21.9774. [Full Text] [PDF]

                                      CORRESPONDENCE

The Amiens Strategy: Small Phase III Trials for Clinically Relevant Progress in the War Against Cancer John J.L. Jacobs, Dainius Characiejus, Rik J. Scheper, Rachel J.E. Stewart, Jurgen F.V. Tan, Radosveta Tomova, Zachary Krastev, and Willem Den Otter JCO Jun 2009: 3062–3063. First published on Apr 27 2009; 10.1200/JCO.2009.22.5359. [Full Text] [PDF]

Reply to J.J.L. Jacobs et al David J. Stewart and Razelle Kurzrock JCO Jun 2009: 3063–3064. First published on Apr 27 2009; 10.1200/JCO.2009.22.5714. [Full Text] [PDF]

Cause-Specific Colostomy Rates After Chemoradiotherapy for Anal Carcinoma: Cancer-Related Versus Treatment-Related Colostomy Dirk Vordermark JCO Jun 2009: 3064. First published on May 4 2009; 10.1200/JCO.2009.22.8890. [Full Text] [PDF]

Reply to D. Vordermark Jaffer A. Ajani JCO Jun 2009: 3065. First published on May 4 2009; 10.1200/JCO.2009.23.0011. [Full Text] [PDF] [Publisher's Note]

Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma? Pentti A. Leppäluoto JCO Jun 2009: 3065–3066. First published on May 11 2009; 10.1200/JCO.2009.22.3420. [Full Text] [PDF]

Reply to P.A. Leppäluoto Anil K. Chaturvedi, Ruth A. Kleinerman, Allan Hildesheim, Ethel S. Gilbert, Hans Storm, Charles F. Lynch, Per Hall, Froydis Langmark, Eero Pukkala, Magnus Kaijser, Michael Andersson, Sophie D. Fossa, Heikki Joensuu, Lois B. Travis, and Eric A. Engels JCO Jun 2009: 3066–3067. First published on May 11 2009; 10.1200/JCO.2009.22.5706. [Full Text] [PDF]

Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor–Positive and Hormone Receptor–Negative Breast Cancer Rita S. Mehta, Donna Jackson, and Toni Schubbert JCO Jun 2009: 3067–3068. First published on May 18 2009; 10.1200/JCO.2009.22.9377. [Full Text] [PDF]

Reply to R.S. Mehta et al Judith Hugh, John Hanson, Maggie Cheang, Torsten Nielsen, Charles Perou, Charles Dumontet, John Reed, Maryla Krajewska, Isabelle Treilleux, Matthieu Rupin, Emmanuelle Magherini, John Mackey, Miguel Martin, and Charles Vogel JCO Jun 2009: 3068–3069. First published on May 18 2009; 10.1200/JCO.2009.23.0607. [Full Text] [PDF]

                                      ERRATA

ERRATUM JCO Jun 2009: 3070. [Full Text] [PDF]

ERRATUM JCO Jun 2009: 3070. [Full Text] [PDF]

ERRATUM JCO Jun 2009: 3070. [Full Text] [PDF]

ERRATUM JCO Jun 2009: 3070–3071. [Full Text] [PDF]

ERRATUM JCO Jun 2009: 3071. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.